Skip to main content
SpringerLink
Log in

Antibodies to p53 may predict a high risk of treatment failure in head and neck cancer

  • Short communication
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Overexpression of p53 as well as the occurrence of serum p53 antibodieshave been correlated to shorter survival and relapse-free intervals in head and neck squamous cell carcinoma (HNSCC). The aim of this study was to reconsider the clinical implications of serum p53 antibodies in HNSCC. Two matched study groups (n=78 patients with HNSCC each), one group positive and one negative for serum p53 antibodies, were followed-up (median of 3 years) regarding the occurrence of relapses, second primaries and tumor related deaths. Tumor relapses (n= 27 vs. 12), second primaries (n= 76 vs. 4) and tumor related deaths (n=21 vs. 9) occurred more frequently in the seropositive group. The results of this study indicate that the presence of serum p53 antibodies in patients with HNSCC points out a group of patients, who have a high risk of treatment failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Angelopoulou, K., Diamandis, E.P., Sutherland, D.J.A. et al. (1994): Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers. International Journal of Cancer 58: 480–487.

    Article  CAS  Google Scholar 

  2. Bourhis, J., Lubin, R., Roche, B. et al. (1996): Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma. journal of the National Cancer Institute 17: 1228–1223.

    Article  Google Scholar 

  3. Crawford, L.V., Pim, D.C., Bulbrook, R.D. et al. (1982): Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. International journal of Cancer 30: 403–408.

    Article  CAS  Google Scholar 

  4. Hong, W.K., Bromer, R.H., Amato, D.Å. et al. (1985): Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy, Cancer 56: 1242–1245.

    Article  PubMed  CAS  Google Scholar 

  5. Houbiers, J.C.A., van der Burg S.H., Watering, van de L.M.G. et al. (1995): Antibodies against p53 are associated with poor prognosis of colorectal cancer. British Journal of Cancer 72: 637–641.

    PubMed  CAS  Google Scholar 

  6. Lavieille, J.P., Lubin, R., Soussi, T. et al. (1996): Analysis of p53 antibody response in patients with sauamous cell carcinoma of the head and neck. Anticancer Research 16: 2385–2388.

    PubMed  CAS  Google Scholar 

  7. Levine, A.J., Perry, M.E., Chang. A. et al. (1994): The Walter Huber Lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. British Journal of Cancer 69: 409–416.

    PubMed  CAS  Google Scholar 

  8. Maass, J.D., Gottschlich, S., Lippert, B. M. et al. (1996): Antikorperbildung gegen das zellulare Protein p53 bei Patienten mit Plattenepithelkarzinomen der oberen Luft- und Speisewege. Laryngo-Rhino-Otologie 75: 53–56.

    Article  PubMed  CAS  Google Scholar 

  9. Maass, J.D., Gottschlich, S., Goeroegh, T. et al. (1997): High rate of p53 overexpression in head and neck carcinomas detected with a refined ELISA. Anticancer Research 17: 473–478.

    PubMed  CAS  Google Scholar 

  10. Momand, J., Zambetti, G.P, Olson, D.C. et al. (1992): The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237–1245.

    Article  PubMed  CAS  Google Scholar 

  11. Peyrat, J.P., Bonneterre, J., Lubin, R. et al. (1995): Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer. Lancet 345: 621–622

    Article  PubMed  CAS  Google Scholar 

  12. Rosenfeld, M.R., Malats, N., Schramm, L., et al. (1977): Serum anti p53 antibodies and prognosis of patients with small cell lung cancer. Journal of the National Cancer Institute 89: 381–384.

    Article  Google Scholar 

  13. Schlichtholz, B., Legros, Y, Gillet, Y. et al. (1992); The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Research 52: 6380–6384.

    PubMed  CAS  Google Scholar 

  14. Shin, D.M., Lee, J.S., Lippmann, S.M. et al. (1996): p53 expression: Predicting recurrence and secondary primary tumors in head and neck squamous cell carcinoma, Journal of the National Cancer Institute 88: 519–529.

    Article  PubMed  CAS  Google Scholar 

  15. UICC, Union internationale Contre le Cancer, TNM-Klassifikation maligner Tumoren. 4, Aufl., Springer, Berlin (1987).

    Google Scholar 

  16. Warnakulasuriya, K.A., Johnson, N.W. (1992): Expression of p53 mutuant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. Journals of Oral Pathology and Medicine 21: 404–408.

    Article  CAS  Google Scholar 

  17. Werner, J.A., Cottschlich, S., Folz, B.J. et al. (1977): p53 serum antibodies as prognostic indicator in head and neck cancer. Cancer Immunology Immunotherapy 44: 112–116.

    Article  Google Scholar 

  18. Yin. X.Y., Smith, M.L., Whiteside, T.L. et al. (1993): Abnormalities in the p53 gene in tumors and cell lines of human squamous cell carcinomas of the head and neck. International Journal of cancer 54: 322–327.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Otolaryngology & Head and Neck Surgery, University of Kiel, Arnold-Heller-Str. 14, 24105, Kiel, Germany

    J. D. Maass, S. Gottschlich, B. M. Lippert, C. Kuelkens, B. J. Folz & J. A. Werner

Authors
  1. J. D. Maass
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Gottschlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. M. Lippert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Kuelkens
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. J. Folz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. A. Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maass, J.D., Gottschlich, S., Lippert, B.M. et al. Antibodies to p53 may predict a high risk of treatment failure in head and neck cancer. IJO & HNS 49, 333–336 (1997). https://doi.org/10.1007/BF02994645

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02994645

Keywords

Search

Navigation